[Summary]Notice Regarding Commencement of the Tender Offer for Shares of Takara Bio Inc. (Securities Code: 4974)2/13TDnetPDF(170KB)
[Summary]Consolidated Financial Statements for the Third Quarter Ended December 31, 2025 FY20262/13TDnetPDF(148KB)
[Updated]Consolidated Financial Statements for the Second Quarter Ended September 30, 202512/18TDnetPDF(426KB)
[Summary]Consolidated Financial Statements for the Second Quarter Ended September 30, 2025 FY202611/11TDnetPDF(195KB)
Revision of Consolidated Business Results Forecasts for the Fiscal Year Ending March 31, 202611/11TDnetPDF(175KB)
[Updated] Consolidated Financial Statements for the First Quarter Ended June 30, 202511/11TDnetPDF(557KB)
Revision of Consolidated Business Results Forecasts for the First Half of the Fiscal Year Ending March 31, 202610/23TDnetPDF(176KB)
Notice Regarding Recording of Extraordinary Income from Sale of Investment Securities10/8TDnetPDF(160KB)
[Summary]Consolidated Financial Statements for the First Quarter Ended June 30, 20258/8TDnetPDF(196KB)
Notice Regarding Recording of Extraordinary Income from Sale of Investment Securities7/7TDnetPDF(260KB)